The human condition and strivings to flourish: Treatments, enhancements, science, and society

Scientific and Philosophical Perspectives in Neuroethics

Volumn , Issue , 2010, Pages 343-354

  Giordano, James J ^b,c  

^a REGINA APOSTOLORUM HOSPITAL   (Italy)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c POTOMAC INSTITUTE FOR POLICY STUDIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79958864694     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1017/CBO9780511676505.019     Document Type: Chapter

References (48)

1. Anderson, G. 2005. Sex and racial differences in pharmacological response: where is the evidence? Pharmacogenetics, pharmacokinetics, and pharmacodynamics. Journal of Women's Health 14(1): 19–29.
2. Baron, J. 2006. Against Bioethics. Cambridge, MA: MIT Press.
3. Boswell, M. V. & Giordano, J. 2009. Evidence-based or evidence-biased: the need to re-appraise and re-align levels of information with stakeholder values. Pain Physician 12: 9–12.
4. Campbell, A. 1995. Health as Liberation. Cleveland, OH: Pilgrim Press.
5. Caplan, A. L. & McHugh, P.R. 2004. Shall we enhance? A debate. Cerebrum 6: 13–29.
6. Cassell, E. 2004. The Nature of Suffering and the Goals of Medicine. Oxford: Oxford University Press.
7. Deacon, T. 1997. The Symbolic Species: The Co-Evolution of Language and the Brain. New York, NY: WW Norton & Company.
8. Flanagan, O. 2002. The Problem of the Soul: Two Visions of Mind and How to Reconcile Them. New York, NY: Basic Books.
9. Fredholm, B. 1995. Adenosine, adenosine receptors and the actions of caffeine. Pharmacology and Toxicology 76(2): 93–101.
10. Gilman, A., Goodman, L. & Gilman, A. 1975. The Pharmacological Basis of Therapeutics. New York: Macmillan.
11. Giordano, J. 2006a. The moral community of the clinical pain medicine encounter. Practical Pain Management 6(5): 60–3.
12. Giordano, J. 2006b. Pain medicine, morality, and the marketplace: time for a change. Practical Pain Management 6(1): 88–9.
13. Giordano, J. & Neale, A. 2007. Daniel Callahan redux – business and medicine, “can this marriage work?” Delaware Medical Journal 79(5): 185–7.
14. Giordano, J. & Pedroni, J. 2007. Pain research: the relationship of knowing and doing. Practical Pain Management 7(5): 28–30.
15. Giordano, J. & Wurzman, R. 2008a. Neurological disease and depression: the possibility and plausibility of putative neuropsychiatric spectrum disorders. Depression: Mind and Body 4(1): 2–5.
16. Giordano, J. & Wurzman, R. 2008b. Chronic pain and substance abuse: spectrum disorder and implications for ethical care. Practical Pain Management 8(6): 53–8.
17. Giordano, J., Garcia, M. K., Boatwright, D. & Klein, K. 2003. Complementary and alternative medicine in mainstream public health: a role for research in fostering integration. Journal of Alternative and Complementary Medicine 9(3): 441–5.
18. Glannon, W. 2006. Bioethics and the Brain. Oxford: Oxford University Press.
19. Glannon, W. 2008. Psychopharmacological enhancement. Neuroethics 1(1): 45–54.
20. Gordijn, B. 2005. Nanoethics: From utopian dreams and apocalyptic nightmares towards a more balanced view. Science and Engineering Ethics 11(4): 521–33.
21. Gow, D. 2002. Anthropology and development: evil twin or moral narrative? Human Organization 61(4): 299–313.
22. Habermas, J. 1970. Technology and science as ideology. In J. J. Shapiro (transl.) Toward a Rational Society. Boston, MA: Beacon, pp. 81–122.
23. Haslam, N. 2003. Categorical versus dimensional models of mental disorder: the taxometric evidence. Australian and New Zealand Journal of Psychiatry 37(6): 696–704.
24. Havercamp, S. & Reiss, S. 2003. A comprehensive assessment of human strivings: test-retest reliability and validity of the Reiss profile. Journal of Personality Assessment 81(2): 123–32.
25. Illich, I. 1976. Limits to Medicine: Medical Nemesis, the Expropriation of Health. New York, NY: Marion Boyars Publishers.
26. Kant, I. (ed.) 1998. Groundwork for the Metaphysics of Morals. Cambridge: Cambridge University Press.
27. Kass, L. 2003. Beyond Therapy: Biotechnology and the Pursuit of Happiness.Washington, D.C.: President's Council on Bioethics.
28. Kelso, J. 1995. Dynamic Patterns: The Self-Organization of Brain and Behavior. Cambridge, MA: MIT Press.
29. Lane, M., Ingram, D. & Roth, G. 2004. The serious search for an antiaging pill. Scientific American 14 (3): 36–41.
30. Langreth, R. 2002. Viagra for the brain. www.forbes.com/forbes/2002/0204/046.html
31. Lenk, H. 1973. Technokratie als Ideologie: Sozialphilosophische Beitrage zu einem Politischen Dilemma. Stuttgart: Kohlhammer.
32. Lyerly, A., Myers, E. & Faden, R. 2001. The ethics of aggregation and hormone replacement therapy. Health Care Analysis 9(2): 187–211.
33. May, W. F. 1975. Code, covenant, contract, or philanthropy. Hastings Center Report 5(6): 29–38.
34. Mondadori, C. 1993. The pharmacology of the nootropics; new insights and new questions. Behavioral Brain Research 59(1–2): 1–9.
35. Morris, D. 2000. Illness and Culture in the Postmodern Age. Berkeley, CA: University of California Press.
36. Nehlig, A., Daval, J. & Debry, G. 1992. Caffeine and the central nervous system: mechanisms of action, biochemical, metabolic and psychostimulant effects. Brain Research Review 17(2): 139–70.
37. Nordenfelt, L. 1995. On the Nature of Health. Dordrecht: Kluwer.
38. Parens, E. 2005. Authenticity and ambivalence: toward understanding the enhancement debate. Hastings Center Report 35(3): 34–41.
39. Pellegrino, E. 1987. Toward a reconstruction of medical morality. Journal of Medical Humanities 8(1): 7–18.
40. Persson, I. & Savulescu, J. 2008. The perils of cognitive enhancement and the urgent imperative to enhance the moral character of humanity. Journal of Applied Philosophy 25(3): 162–77.
41. Pettit, P. 1993. Consequentialism. Hanover: Dartmouth Publishing Company.
42. Rosenberg, W. & Donald, A. 1995. Evidence based medicine: an approach to clinical problem-solving. British Medical Journal 310: 1122–6.
43. Sadler, J. 2005. Values and Psychiatric Diagnosis. Oxford: Oxford University Press.
44. Sisti, D, Caplan, A. & McCartney, J. 2004. Health, Disease, and Illness: Concepts in Medicine. Washington, D.C.: Georgetown University Press.
45. Spear, B., Heath-Chiozzi, M. & Huff, J. 2001. Clinical application of pharmacogenetics. Trends in Molecular Medicine 7(5): 201–4.
46. Tait, G. 2005. The ADHD debate and the philosophy of truth. International Journal of Inclusive Education 9(1): 17–38.
47. Wolpe, P. 2008. Introductory remarks to the panel. First Meeting of Neuroethics Society. Washington, D.C.
48. Wurzman, R., Jonas, W. & Giordano, J. 2008. Pain and depression: potential and possibility for putative spectrum disorders. Pain Practitioner 17(3).